Skip to content

Public FDA record

Z-1266-2022: HeartWare Battery, Model #1650DE, a component of the HeartWare Ventricular Assist Device (HVAD) System.

Recall record Z-1266-2022 for Medtronic Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1266-2022
Company in FDA record
Medtronic Inc
FDA record creation date
Jun 21, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Batteries for the HVAD system have a weld defect affecting internal components within the HVAD battery, resulting in the battery to malfunction and no longer provide power or prevent the battery from holding a complete charge or properly recharging.

Source facts

Action
In the United States, on 5/5/2022, a written Medical Device Retrieval letter dated May 2022 was mailed via 2-day UPS delivery to consignees who have received potentially affected product according to Medtronic records. Outside of the US (OUS), beginning 5/5/2022, an Urgent Medical Device Retrieval letter was being delivered via regionally approved methods to consignees who have received potentially affected product according to Medtronic records. The letter notified customers of the issue description and were provided patient management recommendations. This included reminding their patients to always keep two sources of power connected to their controller and have fully charged spare batteries available at all times. If a [Power Disconnect] alarm occurs while a battery is physically connected, that battery should be taken out of service. The letter references instructions from the patient manual. The consignee actions included immediately identifying and quarantining all affected batteries listed in the attachment; immediately notify patients with affected batteries that Medtronic is conducting this retrieval and have them remove these batteries from service; informed the consignee that the Medtronic Field Representative can assist them in the return of the affected product; complete and return the enclosed Customer Confirmation Form and follow the instructions to initiate an exchange; and share the letter with all those who need to be aware within their organization or to any organization where the affected batteries have been transferred.
Initiated
2022-05-05
Root cause
Process control
Distribution
Worldwide Distribution. US nationwide, Austria, Belgium, Finland, France, Germany, Hungary, Italy, Netherlands, New Zealand, North Macedonia, Norway, Poland, Spain, Switzerland, and the United Kingdom.
Recall number
Z-1266-2022
Recall status
Open, Classified
CDRH record ID
193852
FDA record created
2022-06-21
Recall event number
90228

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗